Attend Virtually or In-Person

November 9th – 11th, 2021 | San Diego, CA

Virtual Special Rate: $995 | In-Person Special Rate: $1,295


November 9th – 11th

More than ever before, the past 18 months has outlined the need for rapid, scalable and cost-effective vaccine, diagnostic, and therapeutic development. It also showcased the importance of flexibility and the need for the biopharmaceutical manufacturing industry to adapt to changing market demands. KENX is excited to announce the Biopharmaceutical Manufacturing University event taking place November 9 – 11 in San Diego. This hybrid-format program will provide you with real world case studies and industry insights as to how the biopharma manufacturing industry can transform for a better future.

Topics Being Covered at the Biopharmaceutical Manufacturing University Hybrid Event Include:

  • Understanding Process Validation in Biotechnology Manufacturing
  • Smart Collaboration – R&D and Manufacturing Breaking Down Barriers for Better Efficiencies
  • Examining How New Technologies are Affecting Biopharmaceutical Manufacturing
  • Reflecting on the Growing Momentum for Biosimilars in the US
  • Creating an Agile Culture to Be Ready to Adapt to New Innovative Ways of Working
  • Discovering how Covid-19 has Changed Biopharmaceutical Manufacturing Forever Delivery
  • Removing Bottlenecks: Improving the Supply Chain for the Biopharma Industry
  • Data Integrity and Biopharmaceutical Manufacturing
  • Remote Observation Technologies – Revolutionizing the Pharma Manufacturing Space
  • Technology Advancements for Drug Product Manufacturing
  • Challenges to Designing and Constructing Optimal Facilities for the Production of Cell & Gene Therapies
  • The Changing Regulatory Processes after The Global Pandemic
  • Cautionary Tales of Centralized Pharmaceutical Manufacturing
  • Advances in Next-Generation Drug Substance Manufacturing of Biologics
  • The Digitization of CMC – The Future for Regulatory Submissions
  • Moving from Change Management to Enterprise Transformation
  • What is the Vision for AI in Biopharma Manufacturing?
  • Data Analytics in Biopharma Manufacturing
  • Barriers to User-Adoption of Innovative Technology in Biopharmaceutical Manufacturing
  • The Potential of Hybrid Process Modeling and Digital Twins to Master the Goals of Bioprocessing 4.0
  • What Does a Modern BioPharmaceutical Manufacturing Facility Look Like?
  • The Rapid Adoption of Intelligent Manufacturing and Pharma 4.0 During Covid
  • Rapid and Cost-Effective Deployment of Modular Biopharma Manufacturing Facilities

Who Should Attend:

Attendees will come from biopharmaceutical companies, pharma, biotech companies, medtech companies and their peripherals across the globe and will bring together all those individuals involved with the manufacturing process.

Titles will include:

  • Chief Engineering Officer
  • Chief Manufacturing Officer
  • Chief Scientific Officer
  • Chief Innovation Officer
  • Chief Technology Officer
  • Chief Operations Officer
  • Chief Quality Officer
  • Chief Data Analytics Officer

VPs/Directors/Managers & Heads of:

  • Manufacturing
  • Engineering
  • R&D / Research & Development
  • Process Improvement
  • Quality
  • Supply Chain
  • Operations
  • Innovation
  • Plant/Site/Facilities
  • Quality
  • Strategy
  • Business Development
  • Technology
  • IT/Information Technology
  • AI
  • Data & Analytics

Register Here